(NASDAQ: CERS) Cerus's forecast annual revenue growth rate of 4.79% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.79%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 58.54%.
Cerus's revenue in 2025 is $225,970,000.On average, 6 Wall Street analysts forecast CERS's revenue for 2025 to be $43,392,566,476, with the lowest CERS revenue forecast at $38,025,641,698, and the highest CERS revenue forecast at $46,652,291,368. On average, 6 Wall Street analysts forecast CERS's revenue for 2026 to be $47,512,843,372, with the lowest CERS revenue forecast at $42,355,293,971, and the highest CERS revenue forecast at $50,301,953,887.
In 2027, CERS is forecast to generate $52,073,000,646 in revenue, with the lowest revenue forecast at $48,002,666,500 and the highest revenue forecast at $54,760,304,785.